Evidence map›Paper›PMID 29085295›Full record

ArticleFrontiers in pharmacology2017

Bioactivity Potential of

Anna Marchelak, Aleksandra Owczarek, Magdalena Matczak, Adam Pawlak, Joanna Kolodziejczyk-Czepas, Pawel Nowak, Monika A Olszewska

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Antioxidants (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Flavonol and A-type procyanidin-rich extracts ofFrontiers in pharmacology · 2023
    Article
  14. Article
  15. Article
  16. Polyphenols and Maillard Reaction Products in DriedMolecules (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Polyphenol-Enriched Extracts ofMolecules (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Bioactivity Potential ofPharmaceuticals (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna MarchelakDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Lodz, Lodz, Poland.
Aleksandra OwczarekDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Lodz, Lodz, Poland.
Magdalena MatczakDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Lodz, Lodz, Poland.
Adam PawlakDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Lodz, Lodz, Poland.
Joanna Kolodziejczyk-CzepasDepartment of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
Pawel NowakDepartment of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
Monika A OlszewskaDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Lodz, Lodz, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flower extracts of

Indexed as

antioxidantshuman plasmahyaluronidaseLC-MSlipoxygenaseoxidative stresspolyphenolsPrunus spinosa

Identifiers

PMID29085295
PMCPMC5649189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.